Accessibility Statement
Skip to main content
Sustainability
Subsidiaries
Partners
Careers
Investors
Contact
Globe
Menu
Menu
Menu closed
Close
Close
Company
Expand mega menu
Expand submenu
Collapse Company
Company
WHO WE ARE
Expand
About Lilly
Key Facts
Recognitions
Powered by Purpose
LEADERSHIP
Expand
Governance
Executive Committee
Board of Directors
POLICIES & REPORTS
Expand
Public Policy
Annual Report & Proxy Statement
Year in Review
Science
Expand mega menu
Expand submenu
Collapse Science
Science
INNOVATION
Expand
Clinical Development Pipeline
Research & Development
Genetic Medicines
Principles of Medical Research
100 Years of Insulin
DISEASE AREAS
Expand
Alzheimer's
Cancer
Diabetes
Immunology
Obesity
Pain
CLINICAL RESEARCH
Expand
Clinical Trials
Diversity in Clinical Trials
Lilly Trials
Expanded Access
CSR Synopses
PARTNERS
Expand
Collaborate With Us
Scientific Areas of Interest
Office of Alliance Management
Lilly Research Award Program
Medicines
Expand mega menu
Expand submenu
Collapse Medicines
Medicines
SAFETY
Expand
Counterfeit Medicines
Patient Safety
Manufacturing & Quality
OUR MEDICINES
Expand
Current Medicines
Historic Medicines
Suggestions for Patients
Your Story Matters
RESOURCES
Expand
Lilly Insulin Access Programs
LillyDirect
Lilly Insulin State Patient Assistance Programs
Lilly Oncology Support Center
Lilly Pricing Information
The Lilly Answers Center
Lilly Cares Foundation
Impact
Expand mega menu
Expand submenu
Collapse Impact
Impact
OUR IMPACT
Expand
Overview
Lilly Foundation
Lilly Grant Office
IMPACT AREAS
Expand
Increase Access to Medicines
Improve Lives and Communities
Empower a Diverse Workforce
Minimize Our Environmental Impact
Operate Ethically and Responsibly
TRANSPARENCY
Expand
Sustainability Report
State-Specific Requirements
News
Expand mega menu
Expand submenu
Collapse News
News
STORIES
Expand
Caring
Science
Policy
All Stories
PRESS RELEASES
Expand
Recent
Archives
MEDIA
Expand
All News
Media Kits
Media Contacts
Social Media Guidelines
Search
Sustainability
Subsidiaries
Partners
Careers
Investors
Contact
Globe
Nick Mayhugh
See More From Nick
